Reporting owner

Moat Ross

Reporting owner CIK 0001857177 · CHIEF OPERATING OFFICER

View SEC filings ↗

These transactions appear in filings associated with this reporting owner. Jointly reported quantities and amounts are unallocated; they are not this owner's individual purchases or total holdings. Names and roles reflect the relevant filing, and a reporting owner may be a person or an organization.

Reset

Transaction timeline & trade size

Choose a reporting owner, transaction period, and security. Open any point for the filing.

Purchases in this page0
Other acquisitions9
Reporting owners1
SalesNot providedCheck original SEC filings

Oct 30, 2026 – Nov 2, 2026 · Transaction dates · Current page sample

Reported quantity · security units

Kiniksa Pharmaceuticals International, plc · Class A Ordinary Share · Exercise / conversion (code M) · Non-derivative · Currency not specified

Reported transaction sizes by transaction dateEach point is one transaction for the selected company, security, and acquisition type. Reporting owners, exact quantities, and values are also provided in the table. These are filing amounts, not a stock-price series.21,0590Kiniksa Pharmaceuticals International, plc · Moat Ross (CHIEF OPERATING OFFICER) · Exercise / conversion · November 2, 2026 · Quantity 6,263 · Price 22.89 · Reference value 143,360.07 · Currency not specifiedKiniksa Pharmaceuticals International, plc · Moat Ross (CHIEF OPERATING OFFICER) · Exercise / conversion · November 2, 2026 · Quantity 12,302 · Price 21.77 · Reference value 267,814.54 · Currency not specifiedKiniksa Pharmaceuticals International, plc · Moat Ross (CHIEF OPERATING OFFICER) · Exercise / conversion · November 2, 2026 · Quantity 9,412 · Price 18.06 · Reference value 169,980.72 · Currency not specifiedKiniksa Pharmaceuticals International, plc · Moat Ross (CHIEF OPERATING OFFICER) · Exercise / conversion · October 30, 2026 · Quantity 10,895 · Price 18.06 · Reference value 196,763.7 · Currency not specifiedKiniksa Pharmaceuticals International, plc · Moat Ross (CHIEF OPERATING OFFICER) · Exercise / conversion · October 30, 2026 · Quantity 16,112 · Price 17.76 · Reference value 286,149.12 · Currency not specifiedKiniksa Pharmaceuticals International, plc · Moat Ross (CHIEF OPERATING OFFICER) · Exercise / conversion · October 30, 2026 · Quantity 1,658 · Price 12.97 · Reference value 21,504.26 · Currency not specifiedKiniksa Pharmaceuticals International, plc · Moat Ross (CHIEF OPERATING OFFICER) · Exercise / conversion · October 30, 2026 · Quantity 3,760 · Price 11.97 · Reference value 45,007.2 · Currency not specifiedKiniksa Pharmaceuticals International, plc · Moat Ross (CHIEF OPERATING OFFICER) · Exercise / conversion · October 30, 2026 · Quantity 21,059 · Price 11.1 · Reference value 233,754.9 · Currency not specifiedKiniksa Pharmaceuticals International, plc · Moat Ross (CHIEF OPERATING OFFICER) · Exercise / conversion · October 30, 2026 · Quantity 16,111 · Price 10.76 · Reference value 173,354.36 · Currency not specifiedOct 30, 2026Nov 2, 2026No reported values to plot for this selection.

Swipe the chart to see the full date range. Exact records are available in the table below.

9 transactions plotted for one security and transaction type. 0 have no reported quantity. A value chart requires a stated currency. Individual reported values remain visible in the table.

PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition

9 dated transactions in this page sample · 1 reporting owners.

View timeline as a table
Transaction dateCompany / securityReporting ownersAcquisition typeQuantityPriceReference valueCurrency
Nov 2, 2026Kiniksa Pharmaceuticals International, plcClass A Ordinary ShareMoat Ross (CHIEF OPERATING OFFICER)Exercise / conversion6,26322.89143,360.07Currency not specified
Nov 2, 2026Kiniksa Pharmaceuticals International, plcClass A Ordinary ShareMoat Ross (CHIEF OPERATING OFFICER)Exercise / conversion12,30221.77267,814.54Currency not specified
Nov 2, 2026Kiniksa Pharmaceuticals International, plcClass A Ordinary ShareMoat Ross (CHIEF OPERATING OFFICER)Exercise / conversion9,41218.06169,980.72Currency not specified
Oct 30, 2026Kiniksa Pharmaceuticals International, plcClass A Ordinary ShareMoat Ross (CHIEF OPERATING OFFICER)Exercise / conversion10,89518.06196,763.7Currency not specified
Oct 30, 2026Kiniksa Pharmaceuticals International, plcClass A Ordinary ShareMoat Ross (CHIEF OPERATING OFFICER)Exercise / conversion16,11217.76286,149.12Currency not specified
Oct 30, 2026Kiniksa Pharmaceuticals International, plcClass A Ordinary ShareMoat Ross (CHIEF OPERATING OFFICER)Exercise / conversion1,65812.9721,504.26Currency not specified
Oct 30, 2026Kiniksa Pharmaceuticals International, plcClass A Ordinary ShareMoat Ross (CHIEF OPERATING OFFICER)Exercise / conversion3,76011.9745,007.2Currency not specified
Oct 30, 2026Kiniksa Pharmaceuticals International, plcClass A Ordinary ShareMoat Ross (CHIEF OPERATING OFFICER)Exercise / conversion21,05911.1233,754.9Currency not specified
Oct 30, 2026Kiniksa Pharmaceuticals International, plcClass A Ordinary ShareMoat Ross (CHIEF OPERATING OFFICER)Exercise / conversion16,11110.76173,354.36Currency not specified

Only transactions on this page are shown. Preset date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.

Transactions in associated filings

Reported insider acquisitions, ordered by filing date, newest first. Currency is shown only when reported.
Filed / transactedCompanyReporting ownersType / securityQuantityPrice / reference valueDetails
Trade: Kiniksa Pharmaceuticals International, plcKNSA · company listings
Moat RossCHIEF OPERATING OFFICER
Exercise / conversionClass A Ordinary ShareNon-derivative security · Code M6,26322.89Value: 143,360.07Currency not specifiedView ↗
Trade: Kiniksa Pharmaceuticals International, plcKNSA · company listings
Moat RossCHIEF OPERATING OFFICER
Exercise / conversionClass A Ordinary ShareNon-derivative security · Code M12,30221.77Value: 267,814.54Currency not specifiedView ↗
Trade: Kiniksa Pharmaceuticals International, plcKNSA · company listings
Moat RossCHIEF OPERATING OFFICER
Exercise / conversionClass A Ordinary ShareNon-derivative security · Code M9,41218.06Value: 169,980.72Currency not specifiedView ↗
Trade: Kiniksa Pharmaceuticals International, plcKNSA · company listings
Moat RossCHIEF OPERATING OFFICER
Exercise / conversionClass A Ordinary ShareNon-derivative security · Code M10,89518.06Value: 196,763.7Currency not specifiedView ↗
Trade: Kiniksa Pharmaceuticals International, plcKNSA · company listings
Moat RossCHIEF OPERATING OFFICER
Exercise / conversionClass A Ordinary ShareNon-derivative security · Code M16,11217.76Value: 286,149.12Currency not specifiedView ↗
Trade: Kiniksa Pharmaceuticals International, plcKNSA · company listings
Moat RossCHIEF OPERATING OFFICER
Exercise / conversionClass A Ordinary ShareNon-derivative security · Code M1,65812.97Value: 21,504.26Currency not specifiedView ↗
Trade: Kiniksa Pharmaceuticals International, plcKNSA · company listings
Moat RossCHIEF OPERATING OFFICER
Exercise / conversionClass A Ordinary ShareNon-derivative security · Code M3,76011.97Value: 45,007.2Currency not specifiedView ↗
Trade: Kiniksa Pharmaceuticals International, plcKNSA · company listings
Moat RossCHIEF OPERATING OFFICER
Exercise / conversionClass A Ordinary ShareNon-derivative security · Code M21,05911.1Value: 233,754.9Currency not specifiedView ↗
Trade: Kiniksa Pharmaceuticals International, plcKNSA · company listings
Moat RossCHIEF OPERATING OFFICER
Exercise / conversionClass A Ordinary ShareNon-derivative security · Code M16,11110.76Value: 173,354.36Currency not specifiedView ↗